cbdMD (YCBD) Acquisitions (2018 - 2019)
cbdMD (YCBD) posted Acquisitions of -$250740.0 for Q3 2019, down 2271.74% sequentially from -$10572.0 in Q2 2019.
cbdMD (YCBD) Acquisitions (2018 - 2019) Analysis & Trends
cbdMD has reported Acquisitions for 2 years, with the latest figure at -$250740.0 in Q3 2019.
- Quarterly Acquisitions changed N/A year-over-year to -$250740.0 in Q3 2019, while the trailing twelve-month figure through Jun 2020 was -$250740.0 (down 121.48% YoY) and the FY2019 annual result came in at $916555.0, changed N/A from the prior year.
- Acquisitions eased to -$250740.0 in Q3 2019 per YCBD's latest filing, from -$10572.0 in the prior quarter.
- Over five years, Acquisitions peaked at $1.2 million in Q4 2018 and troughed at -$250740.0 in Q3 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | - |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -250,740.00 |
| Jun 30, 2019 | -10,572.00 |
| Mar 31, 2019 | 198.00 |
| Dec 31, 2018 | 1.18 Mn |